Analysis of the role of ETV6/FLT3 in oncogenesis, using a murine bone marrow transduction model
| Project/Area Number |
21790913
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Hematology
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
HISHIZAWA Masakatsu Kyoto University, 大学院・医学研究科, 助教 (90444455)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | 血液腫瘍学 / 白血病 / マウス / 融合遺伝子 / FLT3 / ETV6 |
|---|
| Research Abstract |
We identified a novel ETV6/FLT3 variant fusion transcript in myeloproliferative disease (MPD) with T-lymphoblastic leukemia/lymphoma (T-LBL). To investigate the role of ETV6/FLT3 fusion gene in oncogenesis, we used a murine bone marrow transplant model. ETV6/FLT3 induced a rapidly fatal MPD in primary recipient mice. We demonstrated that the Grb2-Gab2 pathway plays an important role in oncogenesis.
|
Report
(3 results)
Research Products
(11 results)
